CEFEPIMEIT IS FOURTH GENERATION ORAL CEPHALOSPORIN, EFFECTIVE AGAINST A WIDE SPECTRUM OF SENSITIVE GRAM POSITIVE, GRAM NEGATIVE & ANAEROBIC BACTERIAL PATHOGENS INCLUDING BETALACTAMASE PRODUCING STRAINS. IT HAS HIGH AFFINITY FOR PENICILLIN-BINDING PROTEINS WITH VARYING SITE OF ACTIVITY. IT ACTS BY INHIBITION OF BACTERIAL CELL-WALL SYNTHESIS.